Results 251 to 260 of about 293,780 (347)

Glucocorticoids after birth trauma and the associated risk of developing posttraumatic stress disorder: a non-randomized open-label pilot trial. [PDF]

Front Glob Womens Health
Kountanis JA, Muzik M, Mentz G, Zhao X, Vlisides PE.   +4 more
europepmc   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source

Frequency and correlates of suicidality in a sample of traumatized treatment-seeking refugees. [PDF]

BMC Psychiatry
Rueger MS, Nehler KJ, Lechner-Meichsner F, Ehring T, Günak MM, Morina N, Kuck S, Mewes R, Giesebrecht J, Weise C, Steil R.   +10 more
europepmc   +1 more source

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

A longitudinal mixed-methods study of barriers and facilitators to the implementation of routine PTSD screening for care-experienced young people. [PDF]

Eur J Psychotraumatol
McGuire R, Meiser-Stedman R, Smith P, Schmidt D, Bjornstad G, Bosworth R, Clarke T, Coombes J, Geijer Simpson E, Hudson K, Oliveira P, Macleod J, McGovern R, Stallard P, Wood K, Hiller RM.   +15 more
europepmc   +1 more source

Ecological momentary assessment of PTSD symptoms and alcohol use in combat veterans.

, 2015
Kyle Possemato, Stephen A. Maisto, Michael Wade, Kimberly Barrie, Shannon McKenzie, Larry J. Lantinga, Paige Ouimette   +6 more
openalex   +1 more source

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

Role of Posttraumatic Stress Disorder Symptoms in Life Adaptation of Toxic Humidifier Disinfectant Survivors: A Multi-Group Analysis. [PDF]

Healthcare (Basel)
Chung Y, Lee MJ, Lee HJ, Kwon SY, Ahn HS, Kim T, Lee SM.   +6 more
europepmc   +1 more source

Clinical Manual for Management of PTSD

, 2012
Steven M. Southwick
openalex   +2 more sources

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source